Dror Bashan Protalix Bio Therapeutics, Inc. (PLX) insider trading activity

PLX Quotes by TradingView

Dror Bashan is PRESIDENT AND CEO of Protalix BioTherapeutics, Inc.. Currently has a direct ownership of 188,516 shares of PLX, which is worth approximately $350,639. The most recent transaction as insider was on Dec 19, 2025, when has been sold 56,000 shares (Common Stock) at a price of $1.81 per share, resulting in proceeds of $101,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 189K
42.26% 3M change
42.26% 12M change
Total Value Held $350,639

Dror Bashan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2025
BUY
Open market or private purchase
$101,360 $1.81 p/Share
56,000 Added 22.9%
188,516 Common Stock
Oct 19 2023
BUY
Open market or private purchase
$90,967 $1.41 p/Share
64,516 Added 32.74%
132,516 Common Stock
Apr 11 2022
BUY
Open market or private purchase
$102,000 $1.5 p/Share
68,000 Added 50.0%
68,000 Common Stock
DB

Dror Bashan

PRESIDENT AND CEO
Carmiel, L3

Track Institutional and Insider Activities on PLX

Follow Protalix BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLX shares.

Notify only if

Insider Trading

Get notified when an Protalix Bio Therapeutics, Inc. insider buys or sells PLX shares.

Notify only if

News

Receive news related to Protalix BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PLX